Patent ID: 8173612

Claim:
A method of treating a malignant tumor in a patient and of treating, or reducing the risk of, a collagen disorder in such patient suffering from, or at risk of, a lung disease relating to the collagen disorder, which comprises: administering therapy to the patient using a therapeutically effective amount of an antisense DNA oligonucleotide which is selected from SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13 and SEQ ID NO:14, or combinations thereof; and administering to the patient at least one chemotherapy drug which itself has a propensity for causing such lung disease.